The World Health Organization has approved Bavarian Nordic's mpox vaccine, the first to be cleared for use in African countries affected by the outbreak. This pre-qualification allows developing nations to access the vaccine, ensuring its safety and efficacy. The Democratic Republic of Congo has been severely impacted, with 37,500 infections and 1,451 deaths reported.
